Study: High-dose losartan doesn't raise death risk in heart patients

04/11/2012 | PhysiciansBriefing.com

A Danish study of more than 6,000 heart failure patients found that those who take a high dose of losartan have the same risk of dying as those taking a high dose of candesartan. The risk of death, however, is higher among heart failure patients who take low- or medium-dose losartan. The findings appear in the Journal of the American Medical Association.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI